SEC Form 4 · accession 0000899243-15-004438
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric S Lander
Director
Period of report
Sep 1, 2015
Accepted (ET)
Sep 3, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 1, 2015 | A | 2,034 | $8.60 | A | 73,741 | D | |
| Common StockF2 | holding | — | — | — | 11,051 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to the issuer's non-employee director compensation program, Dr. Lander has elected to receive this grant of shares in lieu of cash as payment of approximately half of such person's $35,000 annual retainer for service as a director.
- F2These shares are held by the Lander-Weiner Family Trust. Dr. Lander disclaims beneficial ownership of the shares held by the Lander-Weiner Family Trust except to the extent of any pecuniary interest therein.
Remarks
Ex. 24: Limited Power of Attorney